CARMAT Artificial Heart News Conference

A cardiothoracic surgical team with UofL Health – Jewish Hospital and the University of Louisville has performed the world’s first Aeson bioprosthetic total artificial heart implantation in a female patient. The investigational device, currently intended as a bridge to heart transplant, is part of an Early Feasibility Study (EFS) sponsored by CARMAT, a French medical device company, in partnership with UofL, UofL Health – Jewish Hospital and the UofL Health – Trager Transplant Center. https://nam11.safelinks.protection.ou...